[Clinical outcome of potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy for benign prostate hyperplasia]
- PMID: 11449700
- DOI: 10.5980/jpnjurol1989.92.498
[Clinical outcome of potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy for benign prostate hyperplasia]
Abstract
Objective: To study the feasibility of vaporization prostatectomy by potassium-titanyl-phosphate (KTP/532) laser in men with bladder outlet obstruction due to benign prostatic hyperplasia (BPH) and to evaluate their clinical and voiding outcome 2 weeks and 6 months after operation.
Patients and methods: Laser vaporization prostatectomy with the KTP/532 laser at 20 W was performed in 21 BPH patients varying from 56 to 75 years of age. All cases were performed under the spinal anesthesia. The laser was produced by MODEL SL20/50 and ADD/Stat side-firing fibers were used. A urethral catheter was inserted post-operatively and was removed within 6 days after operation. The hemoglobin value was examined on the first day after operation and uroflowmetry was executed 2 weeks and 6 months after operation with the examination of the residual urine volume. IPSS and QOL score were recorded by patients 2 weeks and 6 months after operation.
Results: The prostate volumes ranged from 22 to 52 mL (mean 37.3 +/- 10.4). None of the 21 patients had any significant blood loss or any fluid absorption. The voiding parameters improved: mean peak flow rate increased from 7.1 to 16.5 mL/s 2 weeks after operation and to 15.2 mL/s 6 months after operation and residual volume decreased from 172 to 45 mL 2 weeks after operation and to 43 mL 6 months after operation. IPSS and QOL score improved significantly in Wilcoxon signed-ranks test. The ratio of excellent and good in efficacy criteria of Kawabe group was 71.4% 2 weeks after operation and that was 71.4% 6 months after operation. Mean catheterization term was 4.5 days. Only one patient showed transient urinary retention when the catheter was removed the third postoperative day. None had incontinence postoperatively. No other significant complications were recognized. The prostate volume was more than 50 mL in 3 cases and the postoperative 6 months outcomes of the 3 cases were all poor in their symptoms in the efficacy criteria of Kawabe group.
Conclusions: KTP laser vaporization prostatectomy is safe and effective for obstructive prostates up to 50 mL in volume and produces good results 2 weeks post operatively that are sustained for 6 months after operation.
Similar articles
-
[Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan].Nihon Hinyokika Gakkai Zasshi. 2006 Nov;97(7):815-22. doi: 10.5980/jpnjurol1989.97.815. Nihon Hinyokika Gakkai Zasshi. 2006. PMID: 17154023 Japanese.
-
Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.Eur Urol. 2005 Oct;48(4):608-13. doi: 10.1016/j.eururo.2005.07.013. Eur Urol. 2005. PMID: 16135396
-
High power potassium-titanyl-phosphate laser vaporization prostatectomy.J Urol. 2000 Jun;163(6):1730-3. J Urol. 2000. PMID: 10799170 Clinical Trial.
-
High-power potassium titanyl phosphate laser vaporization prostatectomy.Mayo Clin Proc. 1998 Aug;73(8):798-801. doi: 10.4065/73.8.798. Mayo Clin Proc. 1998. PMID: 9703311 Review.
-
KTP photoselective laser vaporization of the prostate: indications, procedure, and nursing implications.Urol Nurs. 2004 Oct;24(5):373-8; quiz 379. Urol Nurs. 2004. PMID: 15575105 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical